Literature DB >> 25270272

Significance of AKT in gastric cancer (Review).

Takamitsu Sasaki1, Hiroki Kuniyasu2.   

Abstract

AKT is a serine/threonine kinase activated downstream of integrin, which is a receptor for various pro-proliferation and bioactive substances as well as the extracellular matrix receptor. The activation of AKT often contributes to tumorigenesis and plays a role in regulating cell motility, which is critical for local invasion and metastasis. In recent years, it has also drawn attention as a target of new molecular-targeted agents. When analyzing the role of AKT in cancer cells, it is important to consider the microenvironment and variations of cancers. In this review, a basic overview of the role of AKT in normal and malignant tissues is provided, along with an in-depth discussion of its role in gastric cancer and its potential as a target for therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25270272     DOI: 10.3892/ijo.2014.2678

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  29 in total

1.  Evaluation of AKT phosphorylation and PTEN loss and their correlation with the resistance of rituximab in DLBCL.

Authors:  Yihui Ma; Pengyu Zhang; Yi Gao; Huijie Fan; Mingzhi Zhang; Jingjing Wu
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  Profiling and targeting of cellular mitochondrial bioenergetics: inhibition of human gastric cancer cell growth by carnosine.

Authors:  Jiao-Yan Cheng; Jian-Bo Yang; Yuan Liu; Min Xu; Yu-Yan Huang; Jing-Jing Zhang; Pei Cao; Jian-Xin Lyu; Yao Shen
Journal:  Acta Pharmacol Sin       Date:  2018-12-18       Impact factor: 6.150

3.  Gastrointestinal Factor GDDR Attenuates Epithelial-Mesenchymal Transition in Gastric Cancer via Inhibiting AKT Signal.

Authors:  Cheng Fang; Ziqiang Zhang; Chaoxu Liu; Gang Wang; Fei Wang; Zhanwei Zhao; Wenhui Li; Jin Hua; Jianbo Shuang; Jianjun Du
Journal:  Dig Dis Sci       Date:  2016-03-26       Impact factor: 3.199

4.  GKN2 increases apoptosis, reduces the proliferation and invasion ability of gastric cancer cells through down-regulating the JAK/STAT signaling pathway.

Authors:  Jun Ouyang; Xiaohui Pan; Hui Lin; Zecheng Hu; Ping Xiao; Haobin Hu
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

5.  18β-glycyrrhetinic acid inhibits migration and invasion of human gastric cancer cells via the ROS/PKC-α/ERK pathway.

Authors:  Hongke Cai; Xi Chen; Jianbo Zhang; Jijian Wang
Journal:  J Nat Med       Date:  2017-11-02       Impact factor: 2.343

6.  Suppression of SHIP2 contributes to tumorigenesis and proliferation of gastric cancer cells via activation of Akt.

Authors:  Yan Ye; Yan Mei Ge; Miao Miao Xiao; Li Mei Guo; Qun Li; Ji Qing Hao; Jie Da; Wang Lai Hu; Xu Dong Zhang; Jiegou Xu; Lin Jie Zhang
Journal:  J Gastroenterol       Date:  2015-07-23       Impact factor: 7.527

7.  Expression of APPL1 is correlated with clinicopathologic characteristics and poor prognosis in patients with gastric cancer.

Authors:  J S Zhai; J G Song; C H Zhu; K Wu; Y Yao; N Li
Journal:  Curr Oncol       Date:  2016-04-13       Impact factor: 3.677

8.  Silencing A7-nAChR levels increases the sensitivity of gastric cancer cells to ixabepilone treatment.

Authors:  Chao-Chiang Tu; Chien-Yu Huang; Wan-Li Cheng; Chin-Sheng Hung; Yu-Jia Chang; Po-Li Wei
Journal:  Tumour Biol       Date:  2016-01-20

9.  Casein kinase 1 (CK1) promotes the proliferation and metastasis of glioma cells via the phosphatidylinositol 3 kinase-matrix metalloproteinase 2 (AKT-MMP2) pathway.

Authors:  Hua-Song Gao; She-Yu Lin; Xi Han; Hong-Zhi Xu; Yi-Lu Gao; Zhi-Yong Qin
Journal:  Ann Transl Med       Date:  2021-04

Review 10.  Interactions between Autophagy and Bacterial Toxins: Targets for Therapy?

Authors:  Jacques Mathieu
Journal:  Toxins (Basel)       Date:  2015-08-04       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.